オルジェネシスに関するコメント

$オルジェネシス(ORGS.US)$ Orgenesis-Enteredinto Asset Purchase and Strategic Collaboration Agreement Which to Provide Octomera With Over $8 Mln of Initial Collaboration Payments

$オルジェネシス(ORGS.US)$
NEWS
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
Germfree and Orgenesis Inc. announce a strategic partnership to advance cell and gene therapy production. The collaboration aims to reduce production costs, increase accessibility to treatments, and revolutionize the bio-manufacturing industry. Orgenesis will co-market its Octomera platform wit...

$オルジェネシス(ORGS.US)$ Orgenesis Announces $2.3M Private Placement

$オルジェネシス(ORGS.US)$ Press Release: Orgenesis Consortium Awarded EUR2.0M EUR Grant From Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
Dow Jones· just

$オルジェネシス(ORGS.US)$ the next 100x underway? I'm looking to see how cell & gene therapy decentralisation will change the pharmaceutical scenes

$オルジェネシス(ORGS.US)$ New it was coming ! Hehehe

$オルジェネシス(ORGS.US)$Benzinga· 3 mins ago
Orgenesis has entered into a definitive agreement with MM OS Holdings, an affiliate of Metalmark Capital Partners, to acquire its approximate 25% stake in Octomera.
Octomera is Orgenesis's cell processing services subsidiary, and the transaction allows the company to have 100% ownership of this business unit.
In exchange, Metalmark will receive a royalty of 5% of the net revenue of Octomera's cell processing services for the three calendar years 2025-...

$オルジェネシス(ORGS.US)$ KNNBCCB Seetoh Kelvin

$オルジェネシス(ORGS.US)$ Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE